Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 323

1.

Impact of medical comorbidity on the quality of schizophrenia pharmacotherapy in a national VA sample.

Chwastiak L, Rosenheck R, Leslie D.

Med Care. 2006 Jan;44(1):55-61.

PMID:
16365613
[PubMed - indexed for MEDLINE]
2.
3.

Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.

Leslie DL, Rosenheck RA.

J Ment Health Policy Econ. 2003 Sep;6(3):113-21.

PMID:
14646004
[PubMed - indexed for MEDLINE]
4.

Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.

Leslie DL, Mohamed S, Rosenheck RA.

Psychiatr Serv. 2009 Sep;60(9):1175-81. doi: 10.1176/appi.ps.60.9.1175.

PMID:
19723731
[PubMed - indexed for MEDLINE]
5.

Patient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system.

Valenstein M, McCarthy JF, Ignacio RV, Dalack GW, Stavenger T, Blow FC.

Psychiatr Serv. 2006 Jan;57(1):70-6.

PMID:
16399965
[PubMed - indexed for MEDLINE]
6.

The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia.

Leslie DL, Rosenheck R.

J Nerv Ment Dis. 2001 Jun;189(6):377-83.

PMID:
11434638
[PubMed - indexed for MEDLINE]
7.

Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection.

Mohamed S, Rosenheck RA.

J Clin Psychiatry. 2008 Jun;69(6):959-65.

PMID:
18588361
[PubMed - indexed for MEDLINE]
8.

From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.

Leslie DL, Rosenheck RA.

Am J Psychiatry. 2002 Sep;159(9):1534-40.

PMID:
12202274
[PubMed - indexed for MEDLINE]
9.

Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.

Loosbrock DL, Zhao Z, Johnstone BM, Morris LS.

J Ment Health Policy Econ. 2003 Jun;6(2):67-75.

PMID:
14578539
[PubMed - indexed for MEDLINE]
10.

Adherence of schizophrenia pharmacotherapy to published treatment recommendations: patient, facility, and provider predictors.

Leslie DL, Rosenheck RA.

Schizophr Bull. 2004;30(3):649-58.

PMID:
15631257
[PubMed - indexed for MEDLINE]
Free Article
11.

Measuring quality of pharmacotherapy for depression in a national health care system.

Busch SH, Leslie D, Rosenheck R.

Med Care. 2004 Jun;42(6):532-42.

PMID:
15167321
[PubMed - indexed for MEDLINE]
12.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

PMID:
16707074
[PubMed - indexed for MEDLINE]
Free Article
13.

Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.

Mohamed S, Leslie DL, Rosenheck RA.

J Clin Psychiatry. 2009 Jun;70(6):906-12. doi: 10.4088/JCP.08m04450. Epub 2009 May 5.

PMID:
19422760
[PubMed - indexed for MEDLINE]
15.

A pilot study of barriers to medication adherence in schizophrenia.

Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G.

J Clin Psychiatry. 2004 Feb;65(2):211-6.

PMID:
15003075
[PubMed - indexed for MEDLINE]
16.

Administrative prescription review procedures and use of atypical antipsychotic medications in the Department of Veterans Affairs.

Rosenheck R, Leslie D.

Ment Health Serv Res. 2003 Sep;5(3):149-53.

PMID:
15224448
[PubMed - indexed for MEDLINE]
17.

Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals.

Owen RR, Feng W, Thrush CR, Hudson TJ, Austen MA.

Psychiatr Serv. 2001 Nov;52(11):1523-5.

PMID:
11684751
[PubMed - indexed for MEDLINE]
18.

Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.

Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC.

Psychiatr Serv. 2007 Apr;58(4):489-95.

PMID:
17412850
[PubMed - indexed for MEDLINE]
Free PMC Article
19.
20.

Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.

Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M.

Psychiatr Serv. 2007 Feb;58(2):207-12.

PMID:
17287377
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk